PA
PGY icon

PharVision Advisers’s Pagaya Technologies PGY Stock Holding History

PharVision Advisers’s Portfolio PGY Stock Details PGY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,225
Closed -$131K – 111
2026
Q1 		$131K Sell
11,225
-13,392
-54% -$212K 1.33% 22
2025
Q4 		$514K Buy
+24,617
New +$627K 0.26% 37
2025
Q1 		– Sell
-11,749
Closed -$109K – 461
2024
Q4 		$109K Buy
+11,749
New +$124K 0.09% 369

Other funds holding PGY

FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIL
HS Investments IV Ltd St Peter Port $112M AUM
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PharVision Advisers's PGY Position: Q2 2026 in Review

PharVision Advisers sold out of Pagaya Technologies (PGY) in Q2 2026, closing a stake of 11,225 shares — an estimated $131K sold.

PharVision Advisers first reported a position in PGY in Q4 2024 and held it in 3 quarters. The position peaked at $514K in Q4 2025. 222 funds tracked by Wall St. Rank hold PGY as of Q2 2026.

  • PharVision Advisers reported no remaining Pagaya Technologies position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 11,225 Pagaya Technologies shares in Q2 2026, an estimated $131K.
  • PharVision Advisers first reported a position in Pagaya Technologies in Q4 2024 and held it in 3 quarters.
  • PharVision Advisers's Pagaya Technologies position peaked at $514K in Q4 2025.
  • 222 funds tracked by Wall St. Rank held Pagaya Technologies as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.